AzTrials
AzTrials

Sarcopenia;NCT02090192

Effects of Whole-body Vibration in the Frail Elderly

A study testing WBV training and PRT training in people with Sarcopenia; and Osteoporosis, run by Li Zhang at 1 site in China.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Objective: To study the acute and chronic effects of whole-body vibration (WBV) exercises on the lower extremity blood flow, mobility function, balance, muscle strength, bone density, and general health status, and its feasibility as an intervention in frail elderly patients. Design: Randomized controlled trial. Read more about this study

Who is it for?
Ages 75 years and olderHealthy volunteers can take part
Conditions the study is for
Sarcopenia;, Osteoporosis
What is being tested?
WBV training and PRT training
Type of treatment
Surgery or procedure
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
160 participants
Where
1 siteChina
Study dates
Jan 2013to Dec 2015
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • Healthy volunteers accepted
  • Older adult

Who may be able to join

  • ≥75 years old
  • Fried Frailty Criteria
  • Mini Mental State Examination score ≥18

Who cannot join

  • Recent fractures (≤6 months)
  • Gallbladder or kidney stones
  • Malignancies
  • Rheumatic arthritis
  • Epilepsy
  • Serious heart sicknesses or an implant, and bypass stent or cardiac pacemaker
  • Any diseases to be associated with a life expectancy of less than 12 months

Trial locations and contacts

1 site in 1 country.

Li Zhang, Doctor contact

8610-66876335

zhangli781230@163.com

China1 site, 1 recruiting
  • Rehabilitation Department, Nanlou, Chinese PLA general hospital

    Beijing, Beijing Municipality, 100853

    Chunhua Li, Bachelor, 8610-66875462, 18601224462@163.com

    Recruiting

Other trials in China

About this study

Official title: Acute and Chronic Effects of Whole-body Vibration on Mobility, Muscle Strength, Bone and General Health Status in the Frail Elderly

Objective: To study the acute and chronic effects of whole-body vibration (WBV) exercises on the lower extremity blood flow, mobility function, balance, muscle strength, bone density, and general health status, and its feasibility as an intervention in frail elderly patients.

Design: Randomized controlled trial. Subjects: The frail older persons meeting the Fried Frailty Criteria.

Read more

Interventions: All eligible subjects were randomly assigned to 4 groups:

(1) WBV group: Subjects received a whole-body vibration exercise alone; (2) Progressive resistance training (PRT) group: Subjects received progressive resistance training; (3) WBV+ PRT group: Subjects received the whole-body vibration and progressive resistance training; (4) Control group: Subjects received no intervention/training. The periods of intervention are 12 weeks.

Main measures: The lower extremities blood flow (the diameters and red blood cell velocity of the common femoral artery), timed up and go test, 30-second chair stand test, five times sit to stand test, lower extremities muscle strength, balance function, balance confidence, bone density, and general health status was assessed at the beginning of the study, at instant, 12 weeks and 24 month after the intervention.

Study hypothesis: Whole-body vibration exercise is a safe and effective method that can improve the lower extremity blood flow, mobility function, balance, muscle strength, bone density, and general health status in the frail elderly.

Being tested
WBV training, PRT training
Keywords
Whole-body vibration;, Frail Elderly;, Blood flow;, Bone density, Mobility;, Balance;, Muscle strength;, Lower Extremity;, Musculoskeletal System;, Health Status;, Exercise;, Mechanical Oscillation
Medical subject headings
Sarcopenia, Osteoporosis, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • WBV trainingProcedure or surgery

  • PRT trainingProcedure or surgery

Study groups in NCT02090192
Study groupRoleWhat they receive
WBV trainingExperimentalWhole-body vibration training was performed on a commercial Galileo machine (Germany). Participants were required to stand on the moveable rectangular platform and positioned their feet at an equal and standardized distance from the axis of rotation so that the vertical vibration amplitude was 1-3 mm. The frequency was set at 6-26 Hz. The vibration protocol consisted of four to five bouts (60 seconds for each bout), and three to five times a week for 12 weeks. The positions taken by the subjects differed according to their function. Participants who could stand independently were instructed to adopt a "partial squat" position with slight flexion at the hips, knees, and ankle joints to damp the vibrations approximately at the pelvic level.
Receives: Procedure: WBV training
WBV+ PRT trainingExperimentalNot described
Receives: Procedure: WBV training; Procedure: PRT training
PRT trainingActive comparatorNot described
Receives: Procedure: PRT training
Control groupPlacebo comparatorNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Change of the common femoral artery's blood flow from Baseline to 60min post-WBV

    Measured: 60min post-WBV

  2. Change of lower extremities muscle strength from Baseline to 3 month post-WBV

    Measured: 3 month post-WBV

  3. Change of "timed up and go" test (TUGT) from Baseline to 3 month post-WBV

    Measured: 3 month post-WBV

  4. Change of 30-second chair stand test from Baseline to 3 month post-WBV

    Measured: 3 month post-WBV

  5. Change of balance function from Baseline to 3 month post-WBV

    Measured: 3 month post-WBV

  6. Change of balance confidence from Baseline to 3 month post-WBV

    Measured: 3 month post-WBV

  7. Change of bone density from Baseline to 6 month post-WBV

    Measured: 6 month post-WBV

  8. Change of general health status (SF-12 score) from Baseline to 6 month post-WBV

    Measured: 6 month post-WBV

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Mar 2014 (estimated)
  2. Study startJan 2013
  3. Primary completionDec 2015 (estimated)
  4. Study completionDec 2015 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
160 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02090192
Sponsor's protocol ID
ChinaPLAGH-2013FC3009
Status last verified
Mar 2014
First submitted
14 Mar 2014
Last updated
18 Mar 2014
Results posted
No
Data monitoring committee
Yes

Questions about this trial

What is this clinical trial studying?

A study testing WBV training and PRT training in people with Sarcopenia; and Osteoporosis, run by Li Zhang at 1 site in China.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 18 Mar 2014. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in China. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Li Zhang, Doctor (8610-66876335, zhangli781230@163.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Change of the common femoral artery's blood flow from Baseline to 60min post-WBV (time frame: 60min post-WBV). The study lists 8 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 Mar 2014; AzTrials last refreshed its copy on 8 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in